Has Jeffrey Silpe, MD received payments from drug or device companies?

Yes. Drug and device makers reported $131,777 in general payments to Jeffrey Silpe, MD across 180 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Silpe, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Silpe, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Silpe, MD

Vascular Surgery · New Hyde Park, NYNPI 1770903825

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $88,239 of the $131,777 with a category attached, or 67.0%. 13 manufacturers reported payments, led by Stryker at 58.8% of the total. 2025 is the largest year on record at $84,153, more than ten times the $536 reported in 2021. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$131,777in general payments, 2019–2025

Across 180 payments — averaging $732.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$77K
Bard Peripheral Vascular, Inc.$23K
Inari Medical, Inc.$9K
Medtronic$8K
Medical Device Business Services, Inc.$5K
Johnson & Johnson$4K
plus $4K from 7 others

$43,964in research payments, 2019–2025

Across 3 payments — averaging $14,655 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Davol Inc.$30K
Cagent Vascular Inc$14K

What the payments were for

Consulting fees$88,23967%
Speaking & faculty fees$5,5004%
Travel & lodging$26,69120%
Food & beverage$11,3489%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	53	$77,454
Bard Peripheral Vascular, Inc.	34	$23,050
Inari Medical, Inc.	16	$8,576
Medtronic	40	$8,425
Medical Device Business Services, Inc.	10	$5,499
Johnson & Johnson	2	$4,452
Endologix LLC	11	$2,807
Penumbra, Inc.	6	$417
Shockwave Medical, Inc	2	$342
Cvrx, Inc.	2	$293
W. L. Gore & Associates, Inc.	1	$216
Abbott	1	$177
Tactile Systems Technology Inc	2	$69

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CT THROMBECTOMY SYSTEM KIT$72,632
FLOWTRIEVER CATHETER, S$70,557
LIMFLOW SYSTEM$12,458
HawkOne$6,316
PROLENE$4,742
SURGICEL NU-KNIT$4,742
DERMABOND PRINEO$4,452
STRATAFIX$4,452
SURGIFLO Hemostatic Matrix$4,452
VISTASEAL$4,452
Torus Stent Graft System$2,560
ENDOCROSS Device$2,402
VENOVO$1,485
Crosser iQ$887
RotarexS 6 F x 135 cm$553
Lutonix Drug Coated Balloon$428
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$342
Abre$322
Barostim Neo System$293
GORE VIABAHN VBX Balloon Expandable Endo$216

How this compares

$131,777 in reported general payments places this provider in the 90th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024

$273,814

Medicare patients

316

Services billed

1,141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cilostazol	15	$369
Alprazolam	69	$74

Paid to pharmacies, not to this prescriber.

Other vascular surgery in New Hyde Park

Gregg LandisNew Hyde Park$233K
Yana EtkinNew Hyde Park$138K
Gary GelbfishNew York$1.9M
Sundaram RavikumarDobbs Ferry$1.8M
Antonios GasparisHuntington$1.5M
Sonya NoorBuffalo$991K
John LantisNew York$922K
Brian DerubertisNew York$714K
James McKinseyNew York$616K
Peter FariesNew York$494K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →